KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Accured Expenses: 2020-2025

Historic Change in Accured Expenses for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $22.1 million.

  • Ginkgo Bioworks Holdings' Change in Accured Expenses rose 152.70% to $22.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 181.60%. This contributed to the annual value of -$40.4 million for FY2024, which is 339.29% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Change in Accured Expenses stood at $22.1 million for Q3 2025, which was up 291.58% from -$11.5 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Change in Accured Expenses' 5-year high stood at $22.1 million during Q3 2025, with a 5-year trough of -$42.0 million in Q3 2024.
  • Its 3-year average for Change in Accured Expenses is -$595,273, with a median of -$7,000 in 2024.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Change in Accured Expenses skyrocketed by 178.17% in 2023, and later crashed by 164,814.29% in 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Change in Accured Expenses (Quarterly) stood at $15.2 million in 2021, then plummeted by 282.85% to -$27.8 million in 2022, then spiked by 178.17% to $21.7 million in 2023, then plummeted by 143.00% to -$9.3 million in 2024, then skyrocketed by 152.70% to $22.1 million in 2025.
  • Its last three reported values are $22.1 million in Q3 2025, -$11.5 million for Q2 2025, and $6.4 million during Q1 2025.